18,771 Hits in 0.41 sec

Ovarian Cancer Screening

Dr Gauri Rani
2018 Journal of Medical Science And clinical Research  
Once state III & IV ovarian cancer is diagnosed. The survival rate decrease to 20-25%. There is currently no effective strategy for ovarian cancer screening.  ...  Epithelial ovarian cancer is most commonly detected in advanced stage when the overall 5 yrs survival rate is about 20-30%. Detection of early stage ovarian cancer results in improved survival.  ... 
doi:10.18535/jmscr/v6i5.167 fatcat:3kpvijjcqvcnlizufjplwtq7ay

Ovarian Cancer

H. Lambert
1986 Postgraduate medical journal  
The treatment of ovarian cancer remains a serious challenge.  ...  Professor Hudson hopes that new developments in the management of ovarian cancer will soon make this volume obsolete.  ... 
doi:10.1136/pgmj.62.729.706 fatcat:jspcl64p45c23g432sxvdffzim

Ovarian cancer

Elise C. Kohn, Jean Hurteau
2012 Cancer  
We discuss this newest unexpected behavior of ovarian cancer.  ...  Keywords ovarian cancer; KRAS; BRAF; serous; borderline tumor Once again we find epithelial ovarian cancer forging its own path rather than following the classical paths forged by other carcinomas.  ...  Acknowledgments This work was supported by the Intramural Program of the Center for Cancer Research, National Cancer Institute (EK).  ... 
doi:10.1002/cncr.27833 pmid:23233093 pmcid:PMC3553273 fatcat:tpxot242jzg43mvyedvw3o32oi

Ovarian Cancer

Kathleen R. Cho, Ie-Ming Shih
2009 Annual Review of Pathology  
with ovarian cancer.  ...  Mouse models of ovarian carcinoma have been developed that recapitulate many of the morphological features, biological behavior, and gene expression patterns of selected subtypes of ovarian cancer.  ...  type of ovarian cancer.  ... 
doi:10.1146/annurev.pathol.4.110807.092246 pmid:18842102 pmcid:PMC2679364 fatcat:kxsh46pdr5fbpfw2p7tsln7tay

Ovarian Cancer

Alexander Burges, Barbara Schmalfeldt
2011 Deutsches Ärzteblatt International  
Patients with ovarian cancer usually present to a family physician with nonspecific symptoms, most often abdominal pain.  ...  ovarian cancer.  ...  This makes ovarian cancer the fifth most common cancer among women in Germany, after breast, colorectal, lung, and endometrial cancer, with 4.8% of cases. 70% of cases of ovarian cancer are not diagnosed  ... 
doi:10.3238/arztebl.2011.0635 pmid:22025930 pmcid:PMC3198226 fatcat:s3vwexid4jbmrdbv4daw3tjkya

Ovarian cancer

R. Kingston
1997 Postgraduate medical journal  
The chapter on surgery in advanced disease, by comparison, is a model of thoroughness, and is required reading for all clinicians involved in the treatment of ovarian cancer.  ...  Ovarian cancer continues to present the greatest of clinical challenges, and the range of dilemmas posed by the disease is reflected in a steady stream of new texts around the subject, illuminating the  ... 
doi:10.1136/pgmj.73.863.605 fatcat:sje6hwwpivcd3azamvfghpkt7i

Ovarian Cancer

A. E. Dumont, J. L. Whitehall
1980 Ca  
Author's Reply: Thank you for your interest in the article that I wrote on ovarian cancer in Ca. In the beginning, ultrasound gave promise for assisting in the early diagnosis of ovarian cancer.  ...  Barber states, in his article on ovarian cancer, â€oe¿ Patientswith ovarian cancer have an acid reaction of their peritoneal fluid, unlike patients without disease or with a benign process.  ...  cancer was confirmed.  ... 
doi:10.3322/canjclin.30.2.101-b fatcat:ixpa2pdp2bhijekiqakfmgifme

Ovarian cancer

P Kerbrat, C Lhommé, B Fervers, J P Guastalla, L Thomas, N Tournemaine, J P Basuyau, C Cohen-Solal, P Duvillard, T Bachelot, I Ray, E Voog (+1 others)
2001 British Journal of Cancer  
Epithelial ovarian cancer is responsible for 5.8% of cancer deaths. The mortality rate increases with age and two-thirds of the deaths occur after the age of 65.  ...  This SOR covers only the initial management of epithelial ovarian cancer. It does not consider the management of recurrent disease.  ...  In women with a genetically defined risk of ovarian cancer, or in familial forms of ovarian cancer, screening is not recommended outside a formal trial.  ... 
doi:10.1054/bjoc.2000.1758 pmid:11355964 pmcid:PMC2408843 fatcat:3sut5ccy75bqlgbcuwvyjxrktm

Ovarian Cancer

I Judson
1993 British Journal of Cancer  
Yet another book about ovarian cancer, but does it represent a useful contribution?  ...  The basic science section includes excellent reviews on cancer genetics, oncogenes and mechanisms of chemotherapy resistance in the treatment of ovarian cancer.  ... 
doi:10.1038/bjc.1993.517 pmcid:PMC1968652 fatcat:y7pwj7dmtnbdvokvyissh7jl7a

Ovarian Cancer

Yong Sang Song, Hee Seung Kim, Daisuke Aoki, Danny N. Dhanasekaran, Benjamin K. Tsang
2014 BioMed Research International  
ovarian cancer risk. " They found no association between XRCC3 rs861539 polymorphisms and ovarian cancer, whereas they observed a significant correlation with ovarian cancer risk using the homozygote  ...  However, there are still many questions on ovarian carcinogenesis and mechanisms of chemoresistance of ovarian cancer, which need to be resolved to improve the treatment outcomes of ovarian cancer.  ... 
doi:10.1155/2014/764323 pmid:25587539 pmcid:PMC4283453 fatcat:s4mers7plngcpguzl4npt7v67q

Subtypes of Ovarian Cancer and Ovarian Cancer Screening

Masafumi Koshiyama, Noriomi Matsumura, Ikuo Konishi
2017 Diagnostics  
In this paper we discuss current issues, the efficacy and problems associated with ovarian cancer screening, and compare the characteristics of ovarian cancer subtypes.  ...  Ovarian cancer is the foremost cause of gynecological cancer death in the developed world, as it is usually diagnosed at an advanced stage.  ...  The efficacy of ovarian cancer screening depends on the subtypes of ovarian cancer.  ... 
doi:10.3390/diagnostics7010012 pmid:28257098 pmcid:PMC5373021 fatcat:pvp6rdaesbfm7esczhpwp7nk7q

Ovarian cancer (advanced)

Sean Kehoe, Jo Morrison
2009 Clinical evidence  
Ovarian cancer is the fourth most common cause of cancer deaths in the UK. The 5-year relative survival rate in the UK at diagnosis for women aged 15-39 years is nearly 70%.  ...  What are the effects of taxane-based chemotherapy for ovarian cancer that is advanced at first presentation?  ...  [25] Quality of life was measured using a multidimensional questionnaire (Functional Assessment of Cancer Therapy-Ovarian) developed for women with ovarian cancer.  ... 
pmid:19445772 pmcid:PMC2907795 fatcat:rm2i3f6wq5bwdmn7jm4due47ea

Ovarian cancer screening

U. Menon
2004 CMAJ - Canadian Medical Association Journal  
Ovarian cancer screening ONCOLOGY Simple ovarian cyst.  ...  O varian cancer is generally detected at an advanced stage and is associated with a 5year survival rate of about 30%.  ...  High-risk women (those at risk of familial ovarian cancer because of a history of more than 1 first-degree relative with ovarian cancer alone or a combination of early breast and ovarian or colon cancer  ... 
doi:10.1503/cmaj.1031298 pmid:15313987 pmcid:PMC509040 fatcat:saujsnkfjfcvxnw6pudzlysvi4

Familial ovarian cancer

L Elit
2001 Canadian Family Physician  
To assist family physicians in evaluating patients' risk for hereditary ovarian cancer and to review strategies for preventing ovarian cancer.  ...  Of all women who present with ovarian cancer, 20% have a family history of ovarian cancer and 8% carry a BRCA 1 or BRCA 2 mutation.  ...  Twenty percent of women with ovarian cancer have at least one family member with breast or ovarian cancer.  ... 
pmid:11340759 pmcid:PMC2018423 fatcat:dv2lcy6ui5grffs5hw7kqko5ja

Recurrent Ovarian Cancer

J. Pfisterer
2004 Oncology Research and Treatment  
It therefore seems unlikely that this concept will work in recurrent ovarian cancer.  ...  to transfer the results of phase I/II trials to current concepts of treatment of recurrent ovarian cancer.  ... 
doi:10.1159/000075599 pmid:15007243 fatcat:jhw2x4up4vgrfaizm6pcy4fshu
« Previous Showing results 1 — 15 out of 18,771 results